Stay updated on InMed Pharmaceuticals Press Releases
Sign up to get notified when there's something new on the InMed Pharmaceuticals Press Releases page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FLRteQyGNJhOOdkkAaDOTA3q2dv8.uncropped.jpg&w=3840&q=75)
Latest updates to the InMed Pharmaceuticals Press Releases page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoNo Change Detected
- Check5 days agoNo Change Detected
- Check36 days agoChange DetectedThe values for Epidermolysis Bullosa and Glaucoma have swapped positions with the values for Alzheimer’s Disease and Age-related Macular Degeneration in the recent update on the webpage.SummaryDifference4%
- Check45 days agoChange DetectedThe webpage now shows that InMed will be presenting at the Emerging Growth Conference on June 10, 2024, instead of participating in a Fireside Chat with Water Tower Research on July 25, 2023. This indicates a shift in upcoming events and engagements for InMed Pharmaceuticals.SummaryDifference7%
- Check73 days agoChange DetectedThe webpage content has been updated from 'InMed Provides Update on BayMedica Rare Cannabinoid Business July 20, 2023' to 'InMed Pharmaceuticals Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update May 14, 2024'. This change likely represents a recent financial report or business update announcement by InMed Pharmaceuticals.SummaryDifference6%
- Check87 days agoChange DetectedThe value 'Skip to content' on the webpage has been changed to an empty string. This change may indicate an update or modification related to the website's accessibility features or navigation options.SummaryDifference0.5%
- Check113 days agoChange DetectedDifference5%
- Check127 days agoChange DetectedThe webpage has been updated with recent press releases from InMed Pharmaceuticals, including the announcement of InMed being granted a 180-day extension to achieve Nasdaq minimum bid compliance on March 20, 2024, and the report of second fiscal quarter 2024 financial results along with a business update on February 13, 2024.SummaryDifference100%
Stay in the know with updates to InMed Pharmaceuticals Press Releases
Enter your email address, and we'll notify you when there's something new on the InMed Pharmaceuticals Press Releases page.